NO20053087L - Farmasoytisk sammensetning omfattende en LTB4 antagonist og en COX-2 inhibitor eller en kombinert COX 1/2 inhibitor. - Google Patents
Farmasoytisk sammensetning omfattende en LTB4 antagonist og en COX-2 inhibitor eller en kombinert COX 1/2 inhibitor.Info
- Publication number
- NO20053087L NO20053087L NO20053087A NO20053087A NO20053087L NO 20053087 L NO20053087 L NO 20053087L NO 20053087 A NO20053087 A NO 20053087A NO 20053087 A NO20053087 A NO 20053087A NO 20053087 L NO20053087 L NO 20053087L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitor
- cox
- combined
- pharmaceutical composition
- pharmaceutically acceptable
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- VNYSSYRCGWBHLG-AMOLWHMGSA-N leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 101000942305 Zea mays Cytokinin dehydrogenase 1 Proteins 0.000 title 1
- 229940111134 coxibs Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000012453 solvate Substances 0.000 abstract 3
- 101100496968 Caenorhabditis elegans ctc-1 gene Proteins 0.000 abstract 1
- 229940093444 Cyclooxygenase 2 inhibitor Drugs 0.000 abstract 1
- 101100221647 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cox-1 gene Proteins 0.000 abstract 1
- 101150062589 PTGS1 gene Proteins 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical group NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Oppfinnelsen angår en farmasøytisk formulering omfattende en LTB4-antagonist som har en hydroksy- o g en benzamidin-gruppe eller en tautomer, et farmasøytisk akseptabelt salt eller solvat derav, spesielt en forbindelse med formel (I), hvor R og A er som definert i kravene, eller en tautomer, et farmasøytisk akseptabelt salt eller solvat derav (1) og minst én cyklooksygenase-2-inhibitor, en kombinert cox l/2-inhibitor eller et farmasøytisk akseptabelt salt eller solvat derav (2), og en farmasøytisk akseptabel bærer eller tilsetningsmiddel, og eventuelt én eller flere andre terapeutiske bestanddeler.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2622302A | 2002-11-26 | 2002-11-26 | |
| PCT/EP2003/012874 WO2004047824A1 (en) | 2002-11-26 | 2003-11-18 | Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20053087L true NO20053087L (no) | 2005-06-23 |
Family
ID=35295281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053087A NO20053087L (no) | 2002-11-26 | 2005-06-23 | Farmasoytisk sammensetning omfattende en LTB4 antagonist og en COX-2 inhibitor eller en kombinert COX 1/2 inhibitor. |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO20053087L (no) |
-
2005
- 2005-06-23 NO NO20053087A patent/NO20053087L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| NO20090835L (no) | Nye HIV-reverstranskriptaseinhibitorer | |
| TR200103186T2 (tr) | MEK enzimlerinin inhibitörleri olarak kinolin türevleri | |
| MX2009004475A (es) | Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma. | |
| DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| SE0202463D0 (sv) | Novel compounds | |
| ECSP067076A (es) | Derivados de pirimidina urea como inhibidores de la quinasa | |
| SE0400284D0 (sv) | Novel compounds | |
| NO20066055L (no) | Pyridinderivater | |
| NO20051165L (no) | Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet | |
| NO20071617L (no) | Indozolonderivater som 11B-HSD1-inhibitorer | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| EA200500312A1 (ru) | Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз | |
| BR0309343A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| GEP20094605B (en) | Pyrazole derivatives, compositions containing such compounds and methods of use thereof | |
| NO20080801L (no) | Aerosolformulering for inhalering av beta-agonister | |
| BR0309342A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| ECSP045378A (es) | Derivados novedosos de diazabiciclononeno | |
| TW200517106A (en) | Sustained release pharmaceutical compositions | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
| SE0302192D0 (sv) | Novel compounds | |
| NO20040881L (no) | Orale antidiabetes midler. | |
| AU2003250471A8 (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
| UA86776C2 (ru) | Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |